rs765809246

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000836.4(GRIN2D):​c.3321T>A​(p.Asp1107Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000787 in 1,460,980 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00013 ( 1 hom., cov: 31)
Exomes 𝑓: 0.000073 ( 1 hom. )

Consequence

GRIN2D
NM_000836.4 missense

Scores

1
1
17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.277

Publications

1 publications found
Variant links:
Genes affected
GRIN2D (HGNC:4588): (glutamate ionotropic receptor NMDA type subunit 2D) N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: NMDAR2A (GRIN2A), NMDAR2B (GRIN2B), NMDAR2C (GRIN2C), and NMDAR2D (GRIN2D). [provided by RefSeq, Mar 2010]
GRIN2D Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 46
    Inheritance: AD Classification: STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000836.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004858345).
BP6
Variant 19-48443247-T-A is Benign according to our data. Variant chr19-48443247-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 377345.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000129 (19/147286) while in subpopulation AMR AF = 0.000802 (12/14960). AF 95% confidence interval is 0.000462. There are 1 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 19 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000836.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2D
NM_000836.4
MANE Select
c.3321T>Ap.Asp1107Glu
missense
Exon 14 of 14NP_000827.2O15399

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2D
ENST00000263269.4
TSL:1 MANE Select
c.3321T>Ap.Asp1107Glu
missense
Exon 14 of 14ENSP00000263269.2O15399
GRIN2D
ENST00000911262.1
c.3321T>Ap.Asp1107Glu
missense
Exon 13 of 13ENSP00000581321.1

Frequencies

GnomAD3 genomes
AF:
0.000129
AC:
19
AN:
147164
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000803
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000904
Gnomad OTH
AF:
0.000497
GnomAD2 exomes
AF:
0.000416
AC:
58
AN:
139544
AF XY:
0.000391
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000781
Gnomad OTH exome
AF:
0.000599
GnomAD4 exome
AF:
0.0000731
AC:
96
AN:
1313694
Hom.:
1
Cov.:
29
AF XY:
0.0000735
AC XY:
48
AN XY:
652820
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26664
American (AMR)
AF:
0.00162
AC:
53
AN:
32686
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21298
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27492
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76574
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31344
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4230
European-Non Finnish (NFE)
AF:
0.0000365
AC:
38
AN:
1040722
Other (OTH)
AF:
0.0000949
AC:
5
AN:
52684
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000129
AC:
19
AN:
147286
Hom.:
1
Cov.:
31
AF XY:
0.000153
AC XY:
11
AN XY:
71834
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40490
American (AMR)
AF:
0.000802
AC:
12
AN:
14960
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3416
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4800
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
0.0000904
AC:
6
AN:
66374
Other (OTH)
AF:
0.000491
AC:
1
AN:
2036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.554
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000200

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
16
DANN
Benign
0.86
DEOGEN2
Benign
0.098
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.40
T
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N
PhyloP100
-0.28
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.74
N
REVEL
Benign
0.019
Sift
Uncertain
0.0060
D
Sift4G
Benign
1.0
T
Varity_R
0.11
gMVP
0.087
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs765809246;
hg19: chr19-48946504;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.